A Pooled Analysis of Infections, Malignancy, and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease

OBJECTIVES: The objective of this study was to analyze the safety of long-term infliximab treatment, with/without concomitant immunomodulators, across Crohn's disease (CD) and ulcerative colitis (UC) clinical trials. METHODS: To maximize sample size, we pooled primary safety data across 10 CD o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lichtenstein, Gary R, Rutgeerts, Paul, Sandborn, William J, Sands, Bruce E, Diamond, Robert H, Blank, Marion, Montello, Jennifer, Tang, Linda, Cornillie, Freddy, Colombel, Jean-Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390465/
https://www.ncbi.nlm.nih.gov/pubmed/22613901
http://dx.doi.org/10.1038/ajg.2012.89

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390465/
https://www.ncbi.nlm.nih.gov/pubmed/22613901
http://dx.doi.org/10.1038/ajg.2012.89

Ejemplares similares